Corvus Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Corvus Pharmaceuticals, Inc. (CRVS) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $280.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2022-11-03
- 2022-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $280.00K.
- 2022-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $341.00K.
- 2022-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $407.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $478.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2022-09-30 | $280.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $341.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $407.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $478.00K 10-Q · filed 2022-11-03 |
| 2021-09-30 | $555.00K 10-Q · filed 2021-11-01 |
| 2021-06-30 | $145.00K 10-Q · filed 2021-08-02 |
| 2021-03-31 | $194.00K 10-Q · filed 2021-04-29 |
| 2020-12-31 | $249.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $312.00K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $378.00K 10-Q · filed 2020-07-30 |
| 2020-03-31 | $452.00K 10-Q · filed 2020-04-30 |
| 2019-12-31 | $530.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $612.00K 10-Q · filed 2019-10-29 |
| 2019-06-30 | $701.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $794.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |